Literature DB >> 31392146

Should we spare neoadjuvant chemotherapy in low-risk muscle-invasive bladder cancer patients scheduled for radical cystectomy?

Günter Niegisch1.   

Abstract

Entities:  

Year:  2019        PMID： 31392146      PMCID： PMC6642958          DOI： 10.21037/tau.2019.04.04

Source DB:  PubMed          Journal:  Transl Androl Urol        ISSN： 2223-4683


× No keyword cloud information.
  25 in total

Review 1.  Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis.

Authors:  Eric Winquist; Tricia S Kirchner; Roanne Segal; Joseph Chin; Himu Lukka
Journal:  J Urol       Date:  2004-02       Impact factor: 7.450

2.  Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in bladder cancer.

Authors:  Andrea B Apolo; Jamie Riches; Heiko Schöder; Oguz Akin; Alisa Trout; Matthew I Milowsky; Dean F Bajorin
Journal:  J Clin Oncol       Date:  2010-08-02       Impact factor: 44.544

3.  Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration.

Authors: 
Journal:  Eur Urol       Date:  2005-04-21       Impact factor: 20.096

4.  Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy.

Authors:  M L Paik; M J Scolieri; S L Brown; J P Spirnak; M I Resnick
Journal:  J Urol       Date:  2000-06       Impact factor: 7.450

5.  Radical cystectomy for bladder cancer today--a homogeneous series without neoadjuvant therapy.

Authors:  Stephan Madersbacher; Werner Hochreiter; Fiona Burkhard; George N Thalmann; Hansjörg Danuser; Regula Markwalder; Urs E Studer
Journal:  J Clin Oncol       Date:  2003-02-15       Impact factor: 44.544

6.  Evaluation of fluorodeoxyglucose positron-emission tomography with computed tomography for staging of urothelial carcinoma.

Authors:  Michele Lodde; Louis Lacombe; Juan Friede; Francis Morin; Alexandre Saourine; Yves Fradet
Journal:  BJU Int       Date:  2010-09       Impact factor: 5.588

7.  Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findings.

Authors:  Maria Picchio; Uwe Treiber; Ambros J Beer; Stefan Metz; Patrick Bössner; Heiner van Randenborgh; Roger Paul; Gregor Weirich; Michael Souvatzoglou; Rudolf Hartung; Markus Schwaiger; Morand Piert
Journal:  J Nucl Med       Date:  2006-06       Impact factor: 10.057

8.  Computerized tomography for detecting perivesical infiltration and lymph node metastasis in invasive bladder carcinoma.

Authors:  Sumer Baltaci; Berkan Resorlu; Cemil Yagci; Kadir Turkolmez; Cagatay Gogus; Yasar Beduk
Journal:  Urol Int       Date:  2008-12-10       Impact factor: 2.089

9.  FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.

Authors:  Greet Swinnen; Alex Maes; Hans Pottel; Alain Vanneste; Ignace Billiet; Karl Lesage; Patrick Werbrouck
Journal:  Eur Urol       Date:  2009-05-18       Impact factor: 20.096

Review 10.  Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis.

Authors: 
Journal:  Lancet       Date:  2003-06-07       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.